Janet Woodcock and Francis Collins (FDA/NIH)

Covid-19 roundup: FDA and NIH lead­ers con­tin­ue shar­ing lessons from the pan­dem­ic; Slove­nia halts J&J vac­cine roll­out to in­ves­ti­gate death — re­port

Back in March, FDA act­ing com­mis­sion­er Janet Wood­cock and NIH di­rec­tor Fran­cis Collins be­gan the long, slow process of ex­plain­ing some of the lessons they’ve learned since the start of the Covid-19 pan­dem­ic — rang­ing from the lack of re­search in­fra­struc­ture to the im­por­tance of part­ner­ships with in­dus­try.

Yes­ter­day, they went in­to round 2 on what needs to change in prepa­ra­tion for the next pan­dem­ic, point­ing to the White House’s $65 bil­lion Pan­dem­ic Pre­pared­ness Plan.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.